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ABSTRACT
Objectives: Differentiation of delirium and dementia is
a key diagnostic challenge but there has been limited
study of features that distinguish these conditions. We
examined neuropsychiatric and neuropsychological
symptoms in elderly medical inpatients to identify
features that distinguish major neurocognitive
disorders.
Setting: University teaching hospital in Ireland.
Participants and measures: 176 consecutive
elderly medical inpatients (mean age 80.6±7.0 years
(range 60–96); 85 males (48%)) referred to a
psychiatry for later life consultation-liaison service with
Diagnostic and Statistical Manual of Mental Disorders
(DSM) IV delirium, dementia, comorbid delirium–
dementia and cognitively intact controls. Participants
were assessed cross-sectionally with comparison of
scores (including individual items) for the Revised
Delirium Rating Scale (DRS-R98), Cognitive Test
for Delirium (CTD) and Neuropsychiatric Inventory
(NPI-Q).
Results: The frequency of neurocognitive diagnoses
was delirium (n=50), dementia (n=32), comorbid
delirium–dementia (n=62) and cognitively intact
patients (n=32). Both delirium and comorbid delirium–
dementia groups scored higher than the dementia
group for DRS-R98 and CTD total scores, but all three
neurocognitively impaired groups scored similarly in
respect of total NPI-Q scores. For individual DRS-R98
items, delirium groups were distinguished from
dementia groups by a range of non-cognitive
symptoms, but only for impaired attention of the
cognitive items. For the CTD, attention (p=0.002) and
vigilance (p=0.01) distinguished between delirium and
dementia. No individual CTD item distinguished
between comorbid delirium–dementia and delirium. For
the NPI-Q, there were no differences between the three
neurocognitively impaired groups for any individual
item severity.
Conclusions: The neurocognitive profile of delirium is
similar with or without comorbid dementia and differs
from dementia without delirium. Simple tests of
attention and vigilance can help to distinguish between
delirium and other presentations. The NPI-Q does not
readily distinguish between neuropsychiatric
disturbances in delirium versus dementia. Cases of
suspected behavioural and psychological symptoms of
dementia should be carefully assessed for possible
delirium.
INTRODUCTION
Delirium and dementia are major neurocog-
nitive disorders that are both common and
commonly misdiagnosed in hospitalised
elderly.1 2 Improved management of these
under-recognized neuropsychiatric presenta-
tions is a key target within healthcare ser-
vices. Accurate and timely recognition of
Strengths and limitations of this study
▪ This study includes a detailed cross-sectional
assessment comparing the phenomenological
profile of common neurocognitive disorders in
elderly medical patients within a general hospital
setting.
▪ The findings highlight that delirium and dementia
are characterised by different neuropsychiatric
and cognitive disturbances.
▪ Performance on simple bedside tests of attention
and vigilance is disproportionately impaired in
patients with delirium compared to those with
dementia and thus has distinguishing capacity.
▪ The Neuropsychiatric Inventory (NPI) lacks spe-
cificity for the neuropsychiatric disturbances of
dementia over delirium.
▪ Further study should examine how these patterns
are reflected for different dementia subtypes.
Leonard M, et al. BMJ Open 2016;6:e009212. doi:10.1136/bmjopen-2015-009212 1
Open Access Research
group.bmj.com on April 1, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
these disorders is important because delirium is linked
to a variety of adverse outcomes and is frequently the
principal presenting feature of urgent physical illness.
Gonzalez et al,3 for example, found that mortality was
increased by 11% for each additional 48 h of active delir-
ium. Bellelli et al4 found that patients with delirium
superimposed on dementia experience a twofold risk of
death within 1 year, emphasising the need for clear
delineation of this presentation. However, distinction is
complicated by the considerable phenomenological
overlap between these conditions and high comorbidity,
where the prevalence of delirium superimposed on
dementia in community and hospital settings ranges
from 22% to 89%.5
Our understanding of the comparative phenomeno-
logical profile of major neurocognitive disorders is based
on studies conducted in a variety of populations.6–16 These
studies have applied different methods to the assessment
of neuropsychiatric profile but have focused on character-
ising the neuropsychiatric features of comorbid illness
rather than identifying distinguishing features of delirium
versus dementia. Moreover, they have included a limited
account of the range of neuropsychological impairments
that occur in these conditions.
We studied the cognitive and neuropsychiatric profiles
of consecutive referrals of elderly medical inpatients to a
psychiatry for later life consultation-liaison service. In
particular, we aimed to address (1) as to how the neuro-
psychiatric and cognitive profile in comorbid delirium–
dementia compares to that of either disorder alone
when analysed in conjunction with cognitively intact
control patients from the same setting, and (2) which
features best differentiate delirium and dementia,
including comorbid cases.
METHODS
Subjects and design
We conducted a cross-sectional study of neuropsychiatric
symptoms and cognitive performance in consecutive
referrals to a psychiatry for later life consultation-liaison
service at University Hospital Limerick, a 400-bedded
tertiary care centre in the Midwestern region of Ireland.
Between October 2011 and July 2012, cases with altered
mental state suggestive of neurocognitive disorder were
identified on daily rounds by the medical team, and
referred for assessment and diagnosis by the research
team. All patients were ≥60 years old. Patients were
assessed and classified as having delirium, dementia,
comorbid delirium–dementia, or as being cognitively
normal.
Assessments were conducted by raters (DM, ML, JM
and SM) specifically trained in the use of the tools used
in this study (see below), and to further enhance inter-
rater reliability, ratings associated with any uncertainty
were discussed and agreed by consensus between the
raters.
Delirium was diagnosed according to the Diagnostic
and Statistical Manual of Mental Disorders (DSM) IV cri-
teria17 based on a full clinical assessment at the time of
consultation and independent of the Revised Delirium
Rating Scale (DRS-R98), CTD and NPI assessments.
Dementia was defined as a clear history of documented
DSM-IV dementia (based on all available information at
the time of assessment, including clinical case notes and
collateral history from family and/or carers) or a short
Informant Questionnaire on Cognitive Decline in the
Elderly (IQCODE) score of ≥3.5.18–20 Comorbid delir-
ium–dementia was defined as the presence of both dis-
orders. Patients with normal cognition and no history of
cognitive problems were also recruited for assessment.
Each case was then assessed by first completing the
DRS-R98 followed by administration of the CTD. The
DRS-R98 rated the preceding 24 h period whereas the
CTD measured cognition at the time of its administra-
tion. CTD responses were not used to rate DRS-R98
items. The NPI-Q and IQ-CODE were completed on the
same day, and after consultation with family and/or
carers who were familiar with the day-to-day functioning
of the patient over the recent past.
Informed consent
The procedures and rationale for the study were
explained to all patients but because many patients had
cognitive impairment at entry into the study it was pre-
sumed that many might not be capable of giving
informed written consent. Because of the non-invasive
nature of the study, University Hospital Limerick
Regional Ethics Committee approved an approach to
establishing consent by virtue of augmenting patient
assent with proxy consent from next of kin (where pos-
sible), or a responsible caregiver, for all participants, in
accordance with the Helsinki Guidelines for Medical
research involving human subjects.21
Assessments
Demographic data and medication at the time of the
assessment were recorded. All available information
from medical records and collateral history was used.
Nursing staff members were interviewed to assist rating
of symptoms over the previous 24 h.
DRS-R9822 is designed for broad phenomenological
assessment of delirium. It is a 16-item scale with 13 sever-
ity and 3 diagnostic items with high inter-rater reliability,
sensitivity and specificity for detecting delirium in mixed
neuropsychiatric and other hospital populations. Each
item is rated 0 (absent/normal) to 3 (severe impair-
ment) with descriptions anchoring each severity level.
Severity scale scores range from 0 to 39 with higher
scores indicating more severe delirium. Delirium typic-
ally involves scores above 15 (Severity scale) or 18 points
(Total scale) when dementia is in the differential diag-
nosis. For determination of item frequencies in this
study, any item score ≥1 was considered as being
‘present’.
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The Cognitive Test for Delirium (CTD)23 was specifically
designed to assess hospitalised patients with delirium, in
particular those who are intubated or unable to speak or
write. It assesses five neuropsychological domains (orienta-
tion, attention, memory, comprehension and vigilance),
emphasising non-verbal (visual and auditory) modalities.
Each individual domain is scored from 0 to 6 in two point
increments, except for comprehension (single point incre-
ments). Total scores range between 0 and 30, with higher
scores indicating better cognitive function and scores of
<19 consistent with delirium. It reliably differentiates delir-
ium from other neuropsychiatric conditions including
dementia, schizophrenia and depression.23
The Neuropsychiatric Inventory (NPI)24 25 was devel-
oped for assessing neuropsychiatric symptoms in patients
with Alzheimer’s disease and other neurodegenerative
disorders. Studies of cognitively intact older adults indi-
cate extremely low scores suggesting that the NPI is rela-
tively specific for dementia-related neuropsychiatric
pathology. The NPI-Q is a short questionnaire version of
the NPI,25 intended for use in everyday clinical practice.
Neuropsychiatric symptom severity is assessed in the
same way as the original NPI. The NPI-Q includes 10
behavioural and 2 neurovegetative items that are assessed
by an informed caregiver who is knowledgeable about
the patient’s daytime and night-time behaviours.
Symptoms are rated over the past 4 weeks. Each of the 12
symptom domains is assessed by a screening question—
derived from the NPI-Q—that covers symptom manifesta-
tions with anchor points for symptom severity rated on a
three-point scale and caregiver distress ratings rated on a
five-point scale. The questionnaire includes written
instructions and the total NPI-Q severity score represents
the sum of individual symptom scores, and ranges from 0
to 36.26 The NPI can be further divided into four subscales
—agitation/aggression, frontal, mood and psychosis.27
The IQCODE-Short Form (IQCODE-SF) is a validated
screening tool for detecting cognitive impairment.19 The
short version of the IQCODE includes 16 items that rate
cognitive change over time, each of which is rated by an
informant on a five-point Likert scale. The short-IQCODE
takes approximately 10 min to administer. The total score
divided by the number of questions provides a mean item
score where ratings ≥3.5 are considered indicative of long-
standing cognitive difficulties and dementia.
The Delirium Etiology Checklist (DEC)28 was used to
document aetiological underpinnings of delirium. This
standardised checklist captures delirium aetiology
according to 12 categories. The presence and suspected
role of multiple potential causes were documented for
each case of delirium, rated on a five-point scale for
degree of attribution to the delirium episode, ranging
from ‘ruled out/not present/not relevant’ (0) to ‘defin-
ite cause’ (4).
Statistical analyses
Statistical analysis was conducted using SPSS-19.
Demographic and rating scale data are expressed as
means plus SD. Continuous variables (eg, age, total
DRS-R98 and CTD scores) were compared by one way
analysis of variance with independent t tests used for
post hoc comparisons. Although data regarding scores
for individual items on the DRS-R98 and CTD are
shown as means and SDs, these data are not normally
distributed and, as such, statistical comparisons relate to
non-parametric tests (eg, Mann-Whitney U tests for
between group comparisons). Cohen’s d was used to
estimate the effect size for key differences (eg, differ-
ences in CTD item scores).
RESULTS
A total of 176 patients (mean age 80.6±7.0 (range 60–
96); 85 males (48%)) were assessed of whom 50 had
delirium without dementia, 62 had both delirium and
dementia, 32 had dementia without delirium and 32
were deemed cognitively intact. Demographic, medica-
tion and general clinical data for patients from these
four groups are shown in table 1. There were no statistic-
ally significant differences between the four groups in
respect of age, gender distribution, number of medica-
tions received and use of psychotropic medications.
The principal underlying aetiologies for delirium
(n=112) as captured on the DEC were systemic infection
(66), central nervous system infection (4), metabolic/
endocrine disturbance (39), drug intoxication (5), drug
withdrawal (6), cerebrovascular (28), organ insufficiency
(22), seizure-related (12), neoplasm (9) and traumatic
brain injury (2).
Table 1 compares mean scores of the four groups for
the DRS-R98 total and severity scales, CTD, IQ-CODE
and NPI-Q. Both delirium groups were more impaired
than the dementia group on total scores for the
DRS-R98 and CTD. All three neurocognitively impaired
groups scored similarly in respect of total NPI-Q scores.
The mean short IQCODE scores distinguished the
groups, with both dementia groups scoring well in
excess of the suggested cut-off score, and significantly
higher than both, the delirium without dementia and
the control groups.19
Means and SDs for each individual item (1–16) on the
DRS-R98 are described in table 2. The three groups with
cognitive impairment differed from cognitively intact
controls across the majority of items, including both,
cognitive and non-cognitive symptoms. Delirium diag-
nostic items (symptom fluctuation, acute onset and
attributable physical disorder) significantly distinguished
delirium groups from the other groups. In addition,
both delirium groups were distinguished from the
dementia-only group for sleep–wake cycle disturbances,
perceptual disturbances, affective lability and language
abnormalities. Of note, the delirium and dementia
alone groups were not distinguished by cognitive items
(including measures of memory) apart from impaired
attention, which was more severe in both delirium
groups. Both delirium groups were very similar in
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disturbance levels for the majority of items but were dis-
tinguished by severity of sleep–wake cycle disturbance,
thought process abnormalities and motor agitation.
Table 3 shows the comparison of individual CTD item
scores between the four groups. There was a statistically
significant difference overall between the four neurocog-
nitive groups for each of the five individual sections
(p<0.001). No item distinguished between comorbid
delirium–dementia and delirium. Both attention
(p=0.002; d=0.81) and vigilance (p=0.01; d=0.4) distin-
guished delirium from dementia, while only vigilance
significantly distinguished delirium–dementia from
dementia (p<0.001; d=1.8).
The frequencies for each of the 12 individual severity
and distress items for the neurocognitive disorder groups
(delirium alone, comorbid delirium–dementia, demen-
tia and control) are shown in tables 4 and 5. There was
a significant difference overall between the four patient
groups for 10 of the 12 individual distress items of the
NPI-Q. All three neurocognitive groups scored more
highly than controls for anxiety, while the two delirium
groups (but not the dementia-only group) scored more
highly than controls for agitation–aggression, irritability–
lability and aberrant motor behaviour. Conversely, the
dementia groups (but not the delirium alone group)
scored more highly than controls for depression–dys-
phoria and sleep disturbances, while only the comorbid
delirium–dementia group scored more highly than con-
trols for apathy-indifference. Analysis of the NPI-Q sub-
scale scores27 showed significant differences between all
three neurocognitive groups and controls, and broadly
replicated these findings (table 6).
DISCUSSION
We compared the neuropsychiatric profile of elderly
medical inpatients having a variety of neurocognitive
presentations, including patients in a cognitively intact
group. We used well-validated instruments for both delir-
ium and dementia symptom severity—the DRS-R98,
CTD and NPI-Q—which allow for detailed investigation
of cognitive and neuropsychiatric profile in these
complex syndromes. We found that patients with active
delirium—both with and without comorbid dementia—
could be distinguished from patients with
dementia-alone in respect of a range of neuropsychiatric
and cognitive disturbances identified with the DRS-R98
and CTD scales, but less so with the NPI-Q. This suggests
that the NPI-Q does not readily distinguish between the
neuropsychiatric disturbances of delirium and the
so-called Behavioural and Psychological Symptoms of
Dementia (BPSD).
We found similar cognitive and neuropsychiatric
profile in patients with delirium and comorbid delir-
ium–dementia. However, delirium (both comorbid and
without dementia) was distinguished from dementia
without delirium by both a variety of neuropsychiatric
symptoms, and in terms of cognitive performance on
tests of attention and vigilance.
The findings in respect of differences in cognitive
profile between delirium and dementia extends previous
work using similar instrumentation conducted in pallia-
tive care, where attention distinguished both delirium
and comorbid delirium–dementia from dementia
alone.12 In addition, this study of elderly medical inpati-
ents found that performance on vigilance distinguished
patients in both delirium groups from those with
dementia without delirium. Attentional disturbances in
delirium are in respect of the ability to direct, focus,
sustain and shift attention. Vigilance is a term that has
many possible meanings, but is most commonly equated
with the ability to sustain attention to a task and thus is
often referred to as ‘vigilant’ attention.29 The vigilance
test of the CTD used here involves a letter recognition
Table 1 Demographic and medication data for the four patient groups (mean±SD)
Delirium (n=50)
Comorbid delirium–
dementia (n=62) Dementia (n=32) Control (n=32)
Male (%) 55 43 53 41
Age 78.9±9.8 81.1±7.3 80.9±5.0 81.7±7.5
Total number of medications 8.7±3.5 8.8±4.3 9.0±4.5 8.5±4.6
Number of Psychotropics 1.0±1.1 1.4±1.1 1.4±1.2 0.8±1.1
DRS-R98 total 22.0±8.4* 18.9±6.9† 14.0±6.8‡ 6.1±5.2
DRS-R98 severity 17.3±7.4§ 15.1±6.1† 11.8±6.3‡ 4.7±4.1
CTD total 14.6±9.6 14.2±7.7 18.1±8.0‡ 24.6±4.8
Short IQCODE 3.1±0.3 4.2±1.4¶ 4.1±0.7** 2.9±0.6
NPI-Q distress 8.4± 6.4 9.9±7.2 6.7±6.1‡ 1.5±2.1
NPI-Q severity 11.9±10.6 12.3±10.6 10.2±9.5‡ 1.6±2.7
*Delirium > dementia at p<0.001.
†Comorbid delirium–dementia > dementia at p<0.05.
‡All three neurocognitive groups greater than controls at p<0.001.
§Delirium > dementia at p<0.005.
¶Comorbid delirium–dementia > delirium and controls at p<0.001.
**Dementia > delirium and controls at p<0.001.
CTD, Cognitive Test for Delirium; DRS-R98, Revised Delirium Rating Scale; IQCODE, Informant Questionnaire on Cognitive Decline in the
Elderly; NPI-Q, Neuropsychiatric Inventory.
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Table 2 Revised Delirium Rating Scale (DRS-R98) item severities (mean scores±SD) and frequencies (% scoring ≥1 and
≥2) for delirium, comorbid delirium–dementia, dementia-alone and control groups
Controls
(n=32)
Delirium
(n=50)
Comorbid delirium–
dementia (n=62)
Dementia
(n=32)
1. Sleep–wake cycle disturbance 0.5±0.7
44% (9%)
2.0±0.9*†
91% (73%)
1.5±0.9‡
79% (53%)
0.9±0.8§
65% (22%)
2. Perceptual disturbances and
hallucinations
0.2±0.7
6% (6%)
1.0±1.3*
41% (32%)
0.7±1.1‡
37% (23%)
0.2±0.7§
14% (6%)
3. Delusions 0.1±0.6
6% (3%)
0.6±1.0
35% (21%)
0.4±0.8
31% (10%)
0.3±0.7§
15% (9%)
4. Lability of affect 0.2±0.6
6% (3%)
1.4±1.1¶
75% (47%)
1.0±0.9‡
62% (33%)
0.5±0.7
37% (9%)
5. Language 0.1±0.4
6% (3%)
1.1±1.1*
55% (39%)
0.8±1.0‡
43% (23%)
0.3±0.7§
20% (10%)
6. Thought process abnormalities 0.6±0.8
47% (13%)
2.5±4.6‡**
88% (63%)
1.1±1.1
62% (38%)
0.8±0.9§
53% (22%)
7. Motor agitation 0.2±0.5
11% (7%)
1.5±1.1¶†
73% (55%)
0.9±0.9
57% (25%)
0.6±0.8
37% (16%)
8. Motor retardation 0.1±0.4
6% (3%)
0.6±0.9
31% (20%)
0.5±0.8
37% (13%)
0.3±0.6§
19% (3%)
9. Orientation 0.2±0.4
16% (16%)
1.2±1.0
74% (37%)
1.5±0.7‡
90% (52%)
1.0±0.8
70% (22%)
10. Attention 0.6±0.8
37% (15%)
2.4±1.4¶
98% (80%)
2.0±0.9‡
93% (72%)
1.6±1.1
70% (31%)
11. Short-term memory 0.9±0.9
56% (28%)
1.7±1.2
80% (60%)
2.1±0.9
97% (69%)
1.7±1.0
89% (60%)
12. Long-term memory 0.4±0.6
35% (11%)
1.4±1.0
80% (42%)
1.3±0.9
77% (42%)
1.1±1.1
59% (31%)
13.Visuospatial ability 0.6±0.9
34% (22%)
2.1±1.1
89% (70%)
1.8±1.1
85% (60%)
1.6±1.2
73% (60%)
14. Temporal onset of symptoms 0.4±0.6
17% (13%)
2.0±0.6¶**
100% (78%)
1.6±0.9¶
89% (54%)
0.6±0.7
41% (13%)
15. Fluctuation in symptom severity 0.2±0.5
11% (6%)
1.2±0.6¶†
91% (26%)
0.7±0.7*
59% (11%)
0.3±0.4§
27% (27%)
16. Physical disorder 0.8±0.6
72% (10%)
1.9±0.4¶
98% (92%)
1.8±0.4¶
98% (84%)
1.2±0.7
83% (33%)
*More impaired than dementia at p<0.01.
†More impaired than delirium–dementia at p<0.01.
‡More impaired than dementia at p≤0.05.
§No difference between dementia and controls.
¶More impaired than dementia at p<0.001.
**More impaired than delirium–dementia at p≤0.05.
Table 3 Cognitive Test for Delirium (CTD) subscale scores for neurocognitive disorder groups, delirium, comorbid delirium–
dementia, dementia alone and controls
Controls (n=32) Delirium (n=50)
Comorbid delirium–
dementia (n=62) Dementia (n=32)
1. Orientation* 5.8±0.6 3.7±2.4 3.2±2.1 4.3±2.1
2. Attention† 4.7±1.7 2.1±2.1 3.1±2.1 3.8±2.1
3. Memory‡ 5.2±1.1 2.9±2.3 2.3±2.3 3.6±2.0
4. Comprehension§ 5.7±0.5 3.8±2.1 4.1±1.8 4.7±1.7
5. Vigilance¶ 4.3±1.9 1.6±2.2 1.4±2.0 2.5±2.3
*Controls > delirium and comorbid delirium-dementia at p<0.001, and > dementia at p<0.05.
†Controls > delirium at p<0.001 and < comorbid delirium-dementia at p<0.01. Dementia > delirium at p<0.01.
‡Controls > delirium and comorbid delirium-dementia at p<0.001. Comorbid delirium-dementia < dementia at p<0.01.
§Controls > delirium at p<0.001 and < comorbid delirium-dementia at p<0.01.
¶Controls > delirium and comorbid delirium-dementia at p<0.001, and > dementia at p<0.01.
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test and thus explores the ability to sustain attentional
performance. Previous work has highlighted how atten-
tion and vigilance are closely linked, including in
patients with delirium,30 where there was high correl-
ation between DRS-R98 attention (which emphasises the
months backwards test) and CTD attention (which uses
combined performance on the digit span forwards and
backwards) (r=−0.73), as well as between DRS-R98 atten-
tion and CTD vigilance (r=−0.60). Similarly, Brown
et al31 compared performance among patients with delir-
ium, dementia and unimpaired cognition on a series of
tests of sustained visual attention and found that deliri-
ous patients could be distinguished across a range of
tests, while performance among the patients with
dementia was relatively preserved and equivalent to the
unimpaired controls. These findings highlight how
efforts to improve detection of delirium (eg, developing
screening tools) can be enhanced by emphasising
sustained attention/vigilance as key elements within the
cognitive domain.
Neuropsychiatric profiles
Previous comparisons of delirium versus comorbid delir-
ium–dementia in terms of neuropsychiatric profile mea-
sured on the Delirium Symptom Interview in elderly
medical inpatients,6 32 and DRS and BPRS in geropsy-
chiatric patients7 has found that these conditions are
phenomenologically similar. However, other studies using
the Organic Brain Scale in mixed community-dwelling
and hospitalised groups11 14 found that delirious patients
with comorbid dementia have more hyperactive features,
more commonly experience psychotic symptoms, have
more profound communication difficulties and are more
prone to symptom worsening in the evening. Margiotta
et al10 compared DRS profiles in delirious elderly medical
inpatients with and without comorbid dementia. They
Table 4 Frequencies (%) for the 12 individual severity items of the Neuropsychiatric Inventory (NPI) for delirium, comorbid
delirium–dementia, dementia alone and control groups
Controls
(n=32)
Delirium
(n=50)
Comorbid delirium–
dementia (n=62)
Dementia
(n=32) p Value
1. Delusions 1 (3%) 12 (24%) 17 (27%) 5 (15%) ≤0.05
2. Hallucinations 0 (0%) 14 (28%) 21 (34%) 5 (15%) <0.01
3. Agitation/aggression 1 (3%) 23 (46%) 35 (56%) 12 (38%) <0.001
4. Depression/dysphoria 5 (16%) 14 (28%) 30 (48%) 14 (44%) ≤0.05
5. Anxiety 6 (19%) 21 (42%) 31 (50%) 16 (50%) ≤0.05
6. Elation/euphoria 0 (0%) 1 (2%) 7 (11%) 2 (6%) NS
7. Apathy/indifference 2 (6%) 15 (30%) 30 (48%) 9 (28%) <0.001
8. Disinhibition 2 (6%) 8 (16%) 18 (29%) 1 (3%) <0.01
9. Irritability/lability 4 (13%) 23 (46%) 36 (58%) 11 (34%) <0.001
10. Aberrant motor behaviour 2 (7%) 19 (38%) 25 (40%) 9 (28%) <0.01
11. Sleep and night-time
disturbances
3 (9%) 13 (26%) 32 (52%) 12 (37%) <0.001
12. Appetite/eating
disturbances
7 (22%) 16 (32%) 29 (47%) 10 (31%) NS
NS, not significant.
Table 5 Frequencies (%) for the 12 individual distress items of the Neuropsychiatric Inventory (NPI) for delirium, comorbid
delirium–dementia, dementia alone and control groups
Controls
(n=32)
Delirium
(n=50)
Comorbid delirium–
dementia (n=62)
Dementia
(n=32) p Value
1. Delusions 1 (3%) 12 (24%) 17 (27%) 5 (16%) ≤0.05
2. Hallucinations 0 (0%) 15 (30%) 19 (31%) 4 (13%) <0.001
3. Agitation/aggression 1 (3%) 23 (46%) 33 (53%) 12 (38%) <0.001
4. Depression/dysphoria 3 (9%) 15 (30%) 28 (45%) 14 (44%) <0.01
5. Anxiety 5 (16%) 20 (40%) 28 (45%) 15 (47%) ≤0.05
6. Elation/euphoria 0 (0%) 1 (2%) 6 (10%) 2 (6%) NS
7. Apathy/indifference 2 (6%) 12 (24%) 27 (44%) 9 (28%) <0.01
8. Disinhibition 1 (3%) 8 (16%) 15 (24%) 1 (3%) ≤0.05
9. Irritability/lability 3 (9%) 21 (42%) 33 (53%) 11 (34%) <0.001
10. Aberrant motor behaviour 2 (6%) 19 (38%) 20 (32%) 9 (28%) <0.01
11. Sleep and night-time
disturbances
3 (9%) 13 (26%) 31 (50%) 12 (38%) <0.01
12. Appetite/eating disturbances 5 (16%) 16 (32%) 23 (37%) 9 (28%) NS
NS, not significant.
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found that comorbid cases had higher overall DRS
scores, with greater perceptual disturbances and
symptom fluctuation, and experienced more prolonged
delirium episodes. Otherwise, these groups were similar
in terms of other DRS symptoms and Mini-Mental State
Examination scores. We found that the delirium and
comorbid delirium–dementia groups were very similar in
disturbance levels for the majority of symptoms but were
distinguished by severity of DRS-R98 thought process
abnormalities and motor agitation.
Studies that have compared profiles in patients with
dementia with and without comorbid delirium indicate
considerable differences in terms of neuropsychiatric
symptom burden. Landreville et al15 studied long-term
care residents, using the Behaviour Problem Scale, and
found that patients with comorbid delirium–dementia
had greater sleep problems, wandering, irrational behav-
iour and aggression. They suggested that BPSD may be a
risk factor for delirium. Holtta et al13 used the NPI in
dementia patients from acute geriatric inpatient
(n=195) and nursing home settings (n=230), with and
without delirium, and found that the majority of patients
with dementia had multiple neuropsychiatric symptoms
(NPS), but, that comorbid delirium was associated with
greater NPS and a poorer prognosis. In addition,
one-third of dementia patients with multiple NPS had
comorbid delirium. Hasegawa et al16 compared demen-
tia to comorbid delirium–dementia in respect of NPI
ratings in memory clinic attenders. They found signifi-
cantly higher total NPI scores for comorbid delirium–
dementia, with similar scores across the groups for most
individual items except for greater agitation in comorbid
delirium–dementia. They concluded that delirium ‘exag-
gerates’ BPSD in dementia. We found that in compari-
son to dementia patients without delirium, comorbid
delirium–dementia patients had greater DRS-R98 sleep–
wake cycle disturbances, perceptual disturbances, affect-
ive lability and language abnormalities, as well as CTD
impairment of vigilance. However, these two groups did
not differ in respect of NPI-Q ratings.
Two previous studies8 12 have compared phenomeno-
logical profiles in patients with delirium, dementia,
comorbid delirium–dementia and without neurocognitive
disorder. Laurila et al8 supplemented a detailed clinical
assessment with the WAIS and digit span. Dementia
patients with and without delirium differed in respect of
multiple symptoms including attention, disorganised
thinking, perceptual disturbances, sleep difficulties, psy-
chomotor abnormalities, acuity of onset and presence of
aetiology—all of which were more prominent in patients
with comorbid illness. Specific comparison of delirious
patients with and without underlying dementia was not
reported. Meagher et al12 studied palliative care patients,
and found that delirium and comorbid delirium–dementia
groups had comparable DRS-R98 and CTD total scores,
which were greater than in dementia or control groups.
On the DRS-R98, inattention, disorientation and multiple
non-cognitive symptoms (sleep–wake cycle, perceptual
abnormality, affective lability, thought process abnormality,
motor agitation and motor retardation) were more severe
in delirium groups compared with the dementia-alone
group. In this study, we found that both delirium groups
were distinguished from the dementia-only group for
attention, sleep–wake cycle disturbances, perceptual distur-
bances, affective lability, language abnormalities and all
three diagnostic items (acuity of onset, symptom fluctu-
ation and attributable physical disorder).
Trzepacz et al,33 in a comparison of delirium and
dementia without delirium, found greater impairment
in delirium for disturbances of attention, visuospatial
ability, the sleep–wake cycle, perception, thought
process, affective lability, motor agitation, comprehen-
sion, and acuity of onset and fluctuation of symptoms.
Overall, these findings highlight how delirium symp-
toms overshadow dementia when comorbid and, along
with the greater diagnostic urgency for delirium, empha-
sise that elderly medical patients with neuropsychiatric
symptoms should be presumed to have delirium until
otherwise clarified.
Comparison of assessment tools
Although the neuropsychiatric profile of patients varied
according to delirium and dementia status, these pat-
terns differed across the assessment tools employed. The
instruments that we used differ both in their content
and timeframes covered—the CTD exclusively focuses
on cognitive performance at the time of testing, the
DRS-R98 includes cognitive and neurobehavioural
Table 6 Comparison of NPI-Q subscale scores for delirium, comorbid delirium–dementia, dementia alone and control
groups
Controls Delirium
Comorbid delirium–
dementia Dementia
NPIQ4-agitation–aggression 0.3±0.6* 1.8±1.2 1.9±1.4 1.2±1.1†
NPIQ3-mood 0.7±1.0‡ 2.6±2.1 3.0±2.4 2.7±2.2
NPIQ4-frontal 0.4±0.8§ 2.3±2.3 2.9±2.5 1.6±2.2
NPIQ-psychosis 0.0±0.2 1.4±1.7 1.5±2.5 1.4±4.1
*Controls < comorbid delirium and dementia; and delirium ≤0.05.
†Dementia < comorbid delirium–dementia <0.05.
‡Controls < all other neurocognitive groups ≤0.002.
§Controls < comorbid delirium and dementia; and delirium ≤0.005.
NPI-Q, Neuropsychiatric Inventory.
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elements over the previous 24 h, while the NPI-Q
focuses on neuropsychiatric disturbances over the previ-
ous month. Our findings suggest that although patients
with delirium and dementia experience a similar range
of neurobehavioural disturbances (eg, over a month as
measured with the NPI-Q), the relative acuity of delir-
ium is associated with greater symptom burden in the
previous 24 h (as captured on the DRS-R98). In add-
ition, although the DRS-R98 and NPI-Q both assess for
psychosis, sleep–wake cycle disturbance, motor behav-
iour and affective alterations, the emphasis for some fea-
tures is different, whereby NPI-Q explores specifically
for apathy and sustained affective changes, while in the
DRS-R98 the focus is on lability of affective expression.
In particular, the differences between delirium groups
and dementia in respect of DRS-R98 items for sleep,
affective lability and perceptual disturbances, were not
mirrored with the NPI-Q. In addition to the contrasting
time frames covered by these tools, their emphasis
within these domains is different: the DRS-R98 focuses
on alterations to the sleep–wake cycle over the previous
24 h and emphasises fragmentation and cycle reversal in
severity rating. The NPI-Q emphasises sleep at night,
with the range and duration of night-time behaviours
central to rating of severity. Moreover, the NPI-Q is rated
by an informant rather than a psychiatrist. As such, our
findings suggest that the character of sleep disturbances
differs across neurocognitive disorders and that delirium
is particularly characterised by altered sleep–wake cycle.
This echoes previous work that has emphasised that
more severe disturbances involving altered sleep–wake
cycle such as fragmentation and cycle reversal are rela-
tively specific to delirium, and occur in 75% or more of
patients with active delirium.30 34 35
Similarly, we found different patterns in respect of
altered affective functioning. Classically, delirium is asso-
ciated with affective lability while dementia is often com-
plicated by more sustained disturbances of mood, apathy
and indifference. We found that delirium groups had
higher scores for the DRS-R98 item for affective lability,
while only the dementia groups scored higher than con-
trols for depression–dysphoria on the NPI-Q. Affective
disturbances are thus common elements of both delir-
ium and dementia, and are increasingly recognised as
risk factors for both conditions.36 37 More detailed study
of affective symptoms and how they differ across neuro-
cognitive disorders is warranted.
Study limitations
Cross-sectional studies cannot fully capture the phenom-
enological profile of conditions such as delirium, where
symptom fluctuation is prominent, though the DRS-R98
utilises a 24 h reporting period and the NPI-Q captures
symptom profile over the previous month. Our control
group derives from referrals to a psychiatry for later life
service and, as such, is not necessarily representative of
elderly medical inpatients in general. However, it does
provide an appropriate comparison group that reflects
the population in which accurate diagnosis of neuro-
psychiatric problems is most challenging. We could not
specify the stage or primary cause of dementia but evi-
dence indicates that the frequency of different neuro-
psychiatric disturbances varies across dementia types.38 39
The observations regarding sleep and affective changes
can be better explored with tools that have these domains
as their primary focus and that explore different aspects
of each in greater detail in order to ascertain the differ-
ent character of disturbances across neurocognitive syn-
dromes. Finally, the syndromal concept of delirium
remains primarily defined by phenomenological ele-
ments rather than by particular pathophysiological distur-
bances that could define a disease state. The gathering
evidence for biomarkers of delirium can be integrated
with our knowledge from phenomenological studies to
add further precision to the concept of delirium.40
Implications
Guidance regarding differentiating symptoms between
delirium and dementia is relatively lacking in the defin-
ition of delirium in DSM-V41 or International
Classification of Diseases 10,42 suggesting that these diag-
nostic systems would be advanced by criteria to guide
efforts to distinguish these common conditions. This work
suggests that particular neuropsychiatric symptoms and
the methods by which these symptoms are assessed,
including their character and time frame, are key to accur-
ately distinguishing neurocognitive disorders. This is espe-
cially relevant in the assessment of suspected BPSD or
major neurocognitive disorders with behavioural disturb-
ance as described in DSM-V.40 As a general rule, neuro-
psychiatric disturbances captured on the DRS-R98 are
relatively specific for delirium, while disturbances captured
on tools such as the NPI are less discerning between these
major neurocognitive disorders. Given the diagnostic
urgency of delirium, our findings favour use of the
DRS-R98 as the primary symptom assessment tool.
Although delirium and dementia are both characterised
by generalised disturbance of cognitive function, this work
emphasises how delirium can be distinguished from
dementia by virtue of the disproportionate impairment of
attention and vigilance. These cognitive functions should
be emphasised in efforts to identify delirium, including in
populations where there are high rates of dementia.
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